Bill Snyder

November 7, 2013

Community Research Day brings area agencies together

The first Community Research Day, sponsored by the Meharry-Vanderbilt Alliance and the Meharry-Vanderbilt Community-Engaged Research Core, was held Tuesday at the MetroCenter headquarters of United Way of Metropolitan Nashville.

By Bill Snyder
November 7, 2013

Framingham Heart director to speak at VU

Daniel Levy, M.D., director of the famed Framingham Heart Study, will deliver the seventh annual Meredith S. and John A. Oates Lecture in Clinical Pharmacology on Thursday, Nov. 14.

By Bill Snyder
Pills
November 7, 2013

Grant bolsters HIV pharmacy support program

The Vanderbilt Comprehensive Care Clinic has received a nearly $40,000 grant for 2013-2014 from the Baptist Healing Trust (BHT) for its Pharmacy Support Program, which provides free or low-cost medications to people with HIV/AIDS.

By Bill Snyder
October 31, 2013

Pioneers of Discovery: Investigator driven to divine cellular ecosystem’s rulebook

Ken Lau, Ph.D., a new assistant professor in Cell and Developmental Biology, is out to determine the rules that lead to cells converting from one type to another, for example, when a healthy cell becomes a cancer cell.

By Bill Snyder
DNA sequence
October 31, 2013

VU ‘crosslinks’ study sheds light on chemical toxicity

Vanderbilt researchers have characterized the chemical structures of a series of DNA-protein “crosslinks” that may lead to better ways to avoid the cancer-causing potential of environmental chemicals and prevent some drug toxicities.

By Bill Snyder
October 24, 2013

Grad students help achieve key discovery

A multidisciplinary study conducted by the combined efforts of Vanderbilt University graduate students has led to the first evidence that abnormal messenger RNA export from the nucleus to the cytoplasm can cause human disease.

By Bill Snyder
October 24, 2013

Study sheds new light on type 2 diabetes development

Inactivation by oxidative stress of specific transcription factors essential for pancreatic islet beta cell function is a key event in the development of type 2 diabetes, Vanderbilt University researchers and their colleagues have found.
By Bill Snyder
October 21, 2013

Frisse, Weiner elected to Institute of Medicine

Vanderbilt University’s Betsy Weiner, Ph.D., R.N., senior associate dean for Informatics in the School of Nursing, and Mark Frisse, M.D., MS, MBA, Accenture Professor and director of Regional Informatics, have been elected to the Institute of Medicine (IOM), the organization announced this week.
By Bill Snyder
October 17, 2013

Weill Cornell’s Glimcher awarded Vanderbilt Prize

The 2013 Vanderbilt Prize in Biomedical Science has been awarded to Laurie Glimcher, M.D., Stephen and Suzanne Weiss Dean and professor of Medicine at Weill Cornell Medical College in New York City.
By Bill Snyder
October 17, 2013

Synthetic biology expert Collins set to speak at Vanderbilt

Boston University biomedical engineer and MacArthur Fellow James Collins, Ph.D., will lecture at 3:10 p.m. Oct. 23 in the Jacobs Believed in Me Auditorium, part of the Vanderbilt School of Engineering’s Featheringill Hall.
By Bill Snyder
October 11, 2013

New target for stopping inflammation

Importin alpha 5, a member of a family of proteins that “shuttle” other proteins into the nucleus, is a potential new target for drugs to treat inflammatory diseases.
By Bill Snyder
October 10, 2013

Clinical and translational research highlighted at retreat

Kathleen Neuzil, M.D., MPH, known internationally for her efforts to expand vaccine access and delivery around the world, credited her Vanderbilt University mentors last week for guiding her to a career path that allowed her to “make a difference.”
By Bill Snyder